mots c vs retatrutide 🔥 + MOTS-c — The Nutrient Partitioning Stack When researchers look at advanced body composition strategies, the focus is shifting from “eat less” to optimise how calories are used. This is MOTS-C & Retatrutide at the

STEP trials (68 weeks): Patients on semaglutide lost an average of 15% of their body weight, compared to only 2.4% in those using lifestyle changes alone

Side Effects We gave a 5 out of 5 for this category

MuRF-1 and MAFbx/Atrogin-1 (E3 ubiquitin ligases mediating myofibrillar proteolysis) are suppressed 3442% in IGF-1 LR3-treated myotubes under dexamethasone-induced atrophy conditions (1 M Dex, 24 h), demonstrating anti-atrophy activity via Akt-dependent FoxO1/FoxO3a phosphorylation (nuclear exclusion +3844%)

Your provider sets timing, dose ranges, and cycle length based on your labs and response rather than a fixed template, and adjusts over the protocol